Improving clinical trial efficiency using a machine learning-based risk score to enrich study populations.

Using a reliable predictor of mortality such as MARKER-HF to enrich clinical trial populations provides a potential strategy to improve efficiency by requiring a smaller sample size to demonstrate a clinical benefit.